Detailed Information on Publication Record
2013
Granulocyte maturation determines ability to release chromatin NETs and loss of DNA damageresponse; these properties are absent in immature AML granulocytes
LUKÁŠOVÁ, E, Zdeněk KOŘÍSTEK, M KLABUSAY, Vladan ONDŘEJ, S GRIGORYEV et. al.Basic information
Original name
Granulocyte maturation determines ability to release chromatin NETs and loss of DNA damageresponse; these properties are absent in immature AML granulocytes
Authors
LUKÁŠOVÁ, E, Zdeněk KOŘÍSTEK, M KLABUSAY, Vladan ONDŘEJ, S GRIGORYEV, A BAČÍKOVÁ, M ŘEZÁČOVÁ, Martin FALK, J VÁVROVÁ, V KOHÚTOVÁ and Stanislav KOZUBEK
Edition
Biochimica et biophysica acta : Molecular Cell Research, Amsterdam, Elsevier, 2013, 0167-4889
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 5.297
Tags
International impact, Reviewed
Změněno: 2/1/2020 10:49, Mgr. Tereza Miškechová
Abstract
V originále
Terminally-differentiated cells cease to proliferate and acquire specific sets of expressed genes and functions distinguishing them from less differentiated and cancer cells. Mature granulocytes show lobular structure of cell nuclei with highly condensed chromatin in which HP1 proteins are replaced by MNEI. These structural features of chromatin correspond to low level of gene expression and the loss of some important functions as DNA damage repair, shown in this work and, on the other hand, acquisition of a new specific function consisting in the release of chromatin extracellular traps in response to infection by pathogenic microbes. Granulocytic differentiation is incomplete in myeloid leukemia and is manifested by persistence of lower levels of HP1γ and HP1β isoforms. This immaturity is accompanied by acquisition of DDR capacity allowing to these incompletely differentiated multi-lobed neutrophils of AML patients to respond to induction of DSB by γ-irradiation. Immature granulocytes persist frequently in blood of treated AML patients in remission. These granulocytes contrary to mature ones do not release chromatin for NETs after activation with phorbol myristate-12 acetate-13 and do not exert the neutrophil function in immune defence. We suggest therefore the detection of HP1 expression in granulocytes of AML patients as a very sensitive indicator of their maturation and functionality after the treatment. Our results show that the changes in chromatin structure underlie a major transition in functioning of the genome in immature granulocytes. They show further that leukemia stem cells can differentiate ex vivo to mature granulocytes despite carrying the translocation BCR/ABL.
Links
GBP302/12/G157, research and development project |
|